Analysis of IDH1 Mutation Spectrum from Non-Small-Cell Lung Cancer in East Asian Patients

被引：0
作者：
Wang, L. [1 ]
Xu, C. [2 ]
Wang, W. [3 ]
Zhang, Q. [2 ]
Zhuang, W. [2 ]
Zhu, Y. [4 ]
Huang, Z. [2 ]
Chen, G. [5 ]
Fang, M. [3 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构：
[1] Baotou Canc Hosp, Baotou, Peoples R China
[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China
[5] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
non-small-cell lung cancer; IDH1; mutation; prognosis;
D O I：
10.1016/j.jtho.2019.08.2099
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.03-18
引用
收藏
页码：S960 / S960
页数：1
相关论文
共 50 条
  • [31] Clinicopathologic Characteristics and Survival Outcome in East Asian Patients With Non-Small Cell Lung Cancer and FGFR2 Mutations
    Wang, W.
    Xu, C.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S570 - S570
  • [32] Rare mutations in non-small-cell lung cancer
    D'Arcangelo, Manolo
    D'Incecco, Armida
    Cappuzzo, Federico
    FUTURE ONCOLOGY, 2013, 9 (05) : 699 - 711
  • [33] Clinicopathological characteristics of&IT POLE&IT mutation in patients with non-small-cell lung cancer
    Song, Zhengbo
    Cheng, Guoping
    Xu, Chunwei
    Wang, Wenxian
    Shao, Yang
    Zhang, Yiping
    LUNG CANCER, 2018, 118 : 57 - 61
  • [34] NOTCH1 Mutations in East Asian Patients With NonSmall-Cell Lung Cancer
    Song, B.
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Wang, G.
    Wang, Q.
    Song, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1214 - S1214
  • [35] Analysis of DDR2 Gene Aberrations in Chinese Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis
    Lai, J.
    Wang, W.
    Xu, C.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S521 - S522
  • [36] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Zhao, Yiming
    Yi, Junqi
    Xiang, Juanjuan
    Jia, Wei
    Chen, Anqi
    Chen, Liyu
    Zheng, Leliang
    Zhou, Wen
    Wu, Minghua
    Yu, Zheng
    Tang, Jingqun
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [37] Impact of different patterns of metastasis in non-small-cell lung cancer patients
    da Silva, Larissy Machado
    da Silva, Gustavo Telles
    Bergmann, Anke
    Costa, Guilherme Jorge
    Zamboni, Mauro Musa
    Santos Thuler, Luiz Claudio
    FUTURE ONCOLOGY, 2021, 17 (07) : 775 - 782
  • [38] IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome
    Lin, Jiang
    Yao, Dong-ming
    Qian, Jun
    Chen, Qin
    Qian, Wei
    Li, Yun
    Yang, Jing
    Wang, Cui-zhu
    Chai, Hai-yan
    Qian, Zhen
    Xiao, Gao-fei
    Xu, Wen-rong
    ANNALS OF HEMATOLOGY, 2012, 91 (04) : 519 - 525
  • [39] Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer
    Alsdorf, Winfried H.
    Clauditz, Till S.
    Hoenig, Tobias
    Quaas, Alexander
    Sirma, Hueseyin
    Koenig, Alexandra M.
    Izbicki, Jakob
    Sauter, Guido
    Marx, Andreas H.
    Grob, Tobias J.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 155 - 159
  • [40] Application of proteomics in non-small-cell lung cancer
    Cho, William C. S.
    EXPERT REVIEW OF PROTEOMICS, 2016, 13 (01) : 1 - 4
12345